Connect with us

Business

Why the Immutep (ASX:IMM) share price jumped 9% higher today

Published

on

In morning trade the Immutep Ltd (ASX: IMM) share price is storming higher following the release of an announcement.

At the time of writing, the biotechnology company’s shares are up 9% to 42.5 cents.

What did Immutep announce?

This morning the developer of novel immunotherapy treatments for cancer and autoimmune disease announced that it has received a patent entitled “Combined Preparations for the Treatment of Cancer or Infection” by the United States Patent & Trade Mark Office.

According to the release, this US patent follows the grant of the corresponding European patent announced in November 2018.

The claims of the patent protect Immutep’s intellectual property relating to combined preparations comprising its lead…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending